Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
19,68 USD | +0,92% |
|
-0,35% | -5,79% |
Attività
Numero di dipendenti: 4 872
Vendite per attività
HKD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Antibody and Protein Medicine, Pharmaceutical Products and Consultation and Research and Development
100,0
%
| 5 299 | 100,0 % | 6 858 | 100,0 % | +29,43% |
Vendite per regione
HKD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
92,7
%
| 4 806 | 90,7 % | 6 357 | 92,7 % | +32,29% |
United States
7,1
%
| 478 | 9,0 % | 489 | 7,1 % | +2,32% |
Others
0,2
%
| 15 | 0,3 % | 11 | 0,2 % | -24,88% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
De Chao Yu
CEO | Chief Executive Officer | 61 | 28/04/11 |
Fei You
DFI | Director of Finance/CFO | 45 | 05/02 |
Yong-Jun Liu
PSD | President | - | 15/10/20 |
Ghang Shou Gao
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/20 |
Qin Wei Zhou
COO | Chief Operating Officer | 61 | 16/06/16 |
Hao Xi Ede
BRD | Director/Board Member | 65 | 05/06/17 |
Vivian Zhang
HRO | Human Resources Officer | - | 01/03/12 |
Blake Salisbury
PRN | Corporate Officer/Principal | - | 01/03/16 |
Yan Ju Wang
SEC | Corporate Secretary | 36 | 01/10/15 |
Lok Yee Chan
SEC | Corporate Secretary | 35 | 04/06/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Gary Zieziula
BRD | Director/Board Member | 69 | 31/05/22 |
Charles Cooney
BRD | Director/Board Member | 80 | 18/10/15 |
De Chao Yu
CEO | Chief Executive Officer | 61 | 28/04/11 |
I Yin Hsu
BRD | Director/Board Member | 50 | 18/10/18 |
Hao Xi Ede
BRD | Director/Board Member | 65 | 05/06/17 |
Kai Xian Chen
BRD | Director/Board Member | 78 | 18/10/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 1 628 022 690 | 1 512 920 997 ( 92,93 %) | 0 | 92,93 % |
Coordinate società
Innovent Biologics, Inc.
168 Dongping Street Suzhou Industrial Park
215123, Suzhou
+86 512 6956 6088
http://www.innoventbio.com![Indirizzo Innovent Biologics, Inc.(IVBIY)](https://cdn.zonebourse.com/static/address/57530867.png)
Settore
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+2,99% | 95,18 Mrd | |
-4,34% | 37,55 Mrd | |
-10,41% | 33,75 Mrd | |
+75,79% | 28,2 Mrd | |
-14,61% | 15,63 Mrd | |
-3,46% | 13,63 Mrd | |
-12,31% | 11,5 Mrd | |
+184,77% | 10,81 Mrd | |
-54,13% | 9,23 Mrd |
- Borsa valori
- Azioni
- Azione 1801
- Azione IVBIY
- Società Innovent Biologics, Inc.